BACKGROUND _ AIMS: Sacral nerve stimulation is a proven therapeutic option for the treatment of some forms of @entity322 . Very recently, preliminary reports have given evidence for its efficacy in @entity1241 ( @entity1241 ) too. METHODS: Since November 1998, 20 @entity1 have been treated for severe @entity1241 . The cause of @entity1241 was mainly neurologic (n = 15), and was idiopathic in 5 @entity1 . After temporary (subchronic) external stimulation over a period of 10-14 days, @entity1 whose continence status improved underwent implantation of a permanent @entity16922 and a subcutaneously implanted pulse generator. RESULTS: Acute (needle) testing revealed a positive pelvic floor response in 16 @entity1 who underwent subsequent permanent implantation. The median number of @entity322 episodes decreased from 6 episodes (3-15/21 days) to 2 (0-5/21 days). The time period of retention of a volume of saline causing an urge until definitive defecation was 2 minutes (range, 0-5 minutes) preoperatively and increased to 7.5 minutes (2-15 minutes) postoperatively. Results of preoperative and postoperative (3 months) anal manometry showed a statistically significant increase in maximal resting and squeeze pressures. CONCLUSIONS: Sacral nerve stimulation seems to be a new and promising modality for @entity1 with certain types of @entity1241 in whom conventional treatment options have failed to achieve an improvement.

Sacral nerve stimulation as a treatment for XXXX .

@entity1 :: ('9606', 'Species') :: ['patients'] @entity1241 :: ('MESH:D005242', 'Disease') :: ['FI', 'fecal incontinence'] @entity322 :: ('MESH:D014549', 'Disease') :: ['urinary incontinence', 'incontinence'] @entity16922 :: ('MESH:D020265', 'Disease') :: ['quadripolar lead']
@entity1241 :: (MESH:D005242,Disease) :: ['fecal incontinence']
